Skip to main content

Find Clinical Trials

Home
Conditions
Raynaud Disease Secondary to Scleroderma

Clinical trial condition

Raynaud Disease Secondary to Scleroderma

Explore clinical trials studying Raynaud Disease Secondary to Scleroderma. Study availability and eligibility vary by location and protocol.

2 public trials 0 recruiting studies

Refine in advanced search Browse all conditions

Raynaud Disease Secondary to Scleroderma trial results

Not yet recruiting

Efficacy of A Non-Invasive Botulinum Toxin Microneedle Pad for the Treatment of Secondary Raynaud's Phenomenon

NCT07759557

Conditions: Connective Tissue Diseases, Raynaud Disease Secondary to Scleroderma, Scleroderma, Systemic, +3 more
Locations: Not specified

View Trial Details

Completed

Lab Study of MQX-503 in Treatment of Raynaud's

NCT00253331

Conditions: Autoimmune Diseases, Cardiovascular Diseases, Connective Tissue Diseases, +13 more
Locations: Johns Hopkins Bayview Medical Center Baltimore, Maryland, United States

University of Washington Medical College Seattle, Washington, United States

View Trial Details